Substrate inhibition of uracil phosphoribosyltransferase (UPRT) in distinct microbial species and its implications in the phenotype of uracil auxotrophs by Aguiar, Tatiana Quinta et al.
CONFERENCE PROGRAMME
PARTNERS
437  
Microbiotec’17 – Book of Abstracts 
Molecular Microbiology and Microbial Physiology 
P-307 - SUBSTRATE INHIBITION OF URACIL PHOSPHORIBOSYLTRANSFERASE (UPRT) IN DISTINCT 
MICROBIAL SPECIES AND ITS IMPLICATIONS IN THE PHENOTYPE OF URACIL AUXOTROPHS 
 
Tatiana Q. Aguiar1; Rui Silva1; Carla Oliveira1; Lucília Domingues1 
 
1 - CEB – Centre of Biological Engineering, University of Minho, 4710-057 Braga, Portugal 
 
Background  
Unlike the established practice, the supply of exogenous uracil cannot fully rescue uracil auxotrophy in Ura- mutants of 
some species of industrial and/or medical significance (e.g. Ashbya gossypii, Candida guilliermondii, C. albicans, 
Leishmania donovani), which require uridine for proper growth [1-4]. Here we reveal the molecular mechanism underlying 
this phenotype in A. gossypii and disclose common features with protozoan parasites and other flavinogenic/pathogenic 
fungi. 
Method  
Analysis of the A. gossypii Agura3 (Ura- mutant) radial growth on minimal medium containing distinct pyrimidine 
supplements allowed the detection of a bottleneck in the A. gossypii pyrimidine salvage pathway at the Uracil 
Phosphoribosyltransferase (AgUPRT) level. This enzyme catalyzes the production of uridine monophosphate (UMP) from 
uracil and phosphoribosyl pyrophosphate (PRPP), being encoded by AgFUR1. Recombinant AgUPRT was produced and 
purified from Escherichia coli, and its activity characterized spectrophotometrically [4]. 
Results & Conclusions  
Characterization of recombinant AgUPRT revealed that it is susceptible to substrate inhibition by uracil, thus explaining 
the hypersensitivity of A. gossypii Agura3 to uracil and its requirement for uridine [1]. This UPRT substrate inhibition 
mechanism, together with similar Ura- phenotypes, is also present in medically relevant protozoan parasites [4] and 
phenotypic evidences indicate that it likely exists in other flavinogenic fungi [2]. Substrate inhibition of AgUPRT favours 
the preservation of PRPP for use in purine synthesis/salvage. While in A. gossypii and other flavinogenic fungi (e.g., C. 
guilliermondii) purine synthesis is crucial to support the highly active biosynthesis of riboflavin [1-2], in human pathogens 
such as C. albicans and L. donovani the intracellular availability of purines is essential during infection [4-5]. 
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